What does it take to innovate in healthcare? In normal times, it may take 10 years or more, and millions of dollars to get a drug developed or an emerging technology to be widely adopted in the gigantic and complex industry. However, tremendous transformation in healthcare happened during the pandemic in just a few months or weeks which could have taken years. The pandemic has spurred digital transformation at a deep level which is leading to the convergence of technology and healthcare developing faster than ever before. The entire health care industry is on the brink of a revolution.
Trained in emergency medicine and medical informatics, Dr. Halamka, with his more than 25 years leadership positions developing and implementing health care information strategy and policy, is leading Mayo Clinic platform to transform health care by leveraging artificial intelligence, connected health care devices and a network of trusted partners in order to create a healthier world where personalized, predictive and innovative care is accessible to all. Mayo Clinic Platform partners with providers, pharmaceutical companies, medical device companies, health tech startups, patients and payers to drive innovation around diagnosis, treatment and operational improvement.
Chris is the CIO of MGB leading a team of 150 tasked with the commercial application of discoveries of its 75,000 employees. Responsibilities include investing, company creation, international consulting, innovation management, industry collaborations, licensing. Commercialization revenue exceeds $130 million/year & over 225 spin-offs.
Kerrie is the director of Healthcare for Google Cloud. He was with Optum as their first technology fellow, focusing on advancing UnitedHealth Group in AI, ML, deep learning, graph tech, IoT, blockchain, virtual assistants and genomics. Previously, he was VP and CTO at Cisco, as well as a fellow and master inventor with IBM.
Jon is the SVP of Innovation for CCA and MD of Winter Street Ventures, CCA’s healthcare innovation accelerator and venture investment affiliate. His team leverages and deploys capital into new approaches, products and technologies to enhance care coordination and delivery, as well as identifies and supports internal CCA innovations.
Luba is the managing partner of the Dana-Farber Cancer Institute venture fund, lectures at Harvard SEAS, and advises the Wyss Center. She a veteran biotech, digital health and tech investor and company builder, previously at Google Life Sciences (Verily) and Roche. Luba has led $5B+ in deals and investments across multiple tech sectors.
Michael is a cofounder of Flare Capital. Previously, Michael was the founding GP of Flybridge Capital Partners, and earlier in his career was with Polaris Partners, as well as held positions at Wasserstein Perella & Co. and Morgan Stanley & Co. Michael serves on various innovation and investment advisory boards.
Matt is the Managing Director of the Techstars Los Angeles Accelerator. Previously he was the founding and Managing Director for both the Techstars Starburst Space Accelerator and The Cedars-Sinai Accelerator in Partnership with Techstars. He has invested in close to 50 rapidly growing deep tech and healthcare tech companies.
David is an investor and serial entrepreneur. In 1995, David co-founded Firefly, which was acquired by Microsoft in 1998. David later co-founded PeoplePC, which went public in 2001 and was acquired by Earthlink in 2002. In 2005, David co-founded SpotRunner to revolutionize the way advertising was created, planned, bought and sold.
Victor joins Jackson Square Ventures after spending 10 years as a founder and operator of marketplace businesses in healthcare, labor, hardware, and ecommerce. Having experienced successes and failures alike, he loves helping founders of early stage companies build early traction and tackle scaling challenges.
Meet The INNOVATORS
Thought Leaders
Participation
in INNOVATORSverse
Featured on top of
The INNOVATORS
You must be logged in to post a comment.
I see that a hand hygiene startup Pathspot already existed before covid! The founder should say how much revenue have they seen rising since COVID for them?
for me, these startups are all quite impressive. but how can they grow into unicorns are to be seen. maybe that is what this site should do.
Cool stuff! These entrepreneurs are impressive. some already are venture backed with millions. but I think all these companies should tell us more about how they differentiate from their competitors, as some are in very crowded space. The company clearstep, there are already unicorns in the space, how will they compete? The Juli, is in for the hot space of chronic disease management where many startups are in, how they stand out?
great work! Look forward to seeing more exciting innovators!